MBINBIO@EC2607A(26677.HK)

Last Updated 08:00:00
longbridge loading
Company Encyclopedia
View More
name
MBINBIO@EC2607A
26677.HK
News
View More

Innovent Biologics: Rising Star in Biopharma

Innovent Biologics is emerging as a leader in China's biopharma sector, shifting from generics to innovative biopharmaceuticals. With revenues projected to reach USD 126.6 billion by 2030, the company has launched 18 products and has a robust pipeline. In Q3 2025, it reported a 40% year-on-year revenue increase, driven by successful oncology drugs. Analysts are optimistic, with a consensus target price indicating a potential 25.5% upside. However, challenges such as regulatory pressures and competition remain. Innovent's focus on innovation positions it for significant growth in the global biopharma landscape.

marketscreener·
HK
01801
-2.52%
marketscreener·
HK
01801
-2.52%

Innovent Biologics Reports Positive Phase 1b Results for IBI324 in Eye Disease Trial

Innovent Biologics Inc. and Ollin Biosciences reported positive Phase 1b results for IBI324 in a clinical trial for diabetic macular edema and wet age-related macular degeneration. The study showed IBI324's superior outcomes compared to faricimab, with plans to advance to global Phase 3 studies. Full results will be presented at a symposium in February 2026.

Reuters·
HK
01801
-2.52%
Reuters·
HK
01801
-2.52%

Hong Kong stock movement: The innovative drug industry explodes, REMEGEN rises 10.04%

REMEGEN rose 10.04%; Innovent Biologics rose 4.20%, with a transaction volume reaching HKD 1.214 billion; CanSino Biologics rose 5.48%, with a transaction volume reaching HKD 1.058 billion; BeiGene rose 1.92%, with a transaction volume reaching HKD 844 million; Kelun-Biotech rose 4.31%, with a market value reaching HKD 107.3 billion

HK Stock Movers Tracker·
HK
09995
-1.26%
HK
01801
-2.52%
HK
09926
+0.26%
HK Stock Movers Tracker·
HK
09995
-1.26%
HK
01801
-2.52%
HK
09926
+0.26%

Health care roundup: Market talk

Find insight on Innovent, Raffles Medical Group and more in the latest Market Talks covering the Health Care sector.

MSN·
HK
01801
-2.52%
SG
BSL
0.00%
MSN·
HK
01801
-2.52%
SG
BSL
0.00%

Top 5 HK Stock Gainers/Losers (>100B) (1.5)

KUAISHOU-W(01024) rose 11.09%, with a trading turnover 9.9 Billion HKD, and a year-to-date rose 15.1%. SKB BIO-B(06990) rose 7.84%, with a trading turnover 419.7 Million HKD, and a year-to-date rose 10.1%. GWMOTOR(02333) fell 6.15%, with a trading turnover 580.4 Million HKD, and a year-to-date fell 7.3%. CTG DUTY-FREE(01880) fell 4.96%, with a trading turnover 419.3 Million HKD, and a year-to-date fell 2.9%.

Top Gainers & Losers·
HK
01024
-0.91%
HK
06990
-1.25%
HK
01801
-2.52%
Top Gainers & Losers·
HK
01024
-0.91%
HK
06990
-1.25%
HK
01801
-2.52%
Posts
View More
© 2026 Longbridge｜Disclaimer